ADAs	Antidrug antibodies
APCs	Antigen-presenting cells
CHO	Chinese hamster ovary
CRIM	Cross-reactive immunologic material
eGFR	Estimated glomerular filtration rate
ERT	Enzyme replacement therapy
FOS	Fabry Outcome Survey
Gb3	Globotriaosylceramide
GLA	α-galactosidase A
GSL	Glycosphingolipids
IA	Immunoadsorption
IAR	Immune adverse reaction
IRRs	Infusion-related reactions
IS	Immunosuppressive
IVIG	Intravenous immunoglobulin
LSD	Lysosomal storage disease
LysoGb3	Globotriaosylsphingosine
M6P	Mannose-6-phosphate
NGNA	N-glycolylneuraminic acid
OS	Oxidative stress
PAF	Platelet activating factor
PMS	Post-marketing surveillance
QoL	Quality of life
RCTs	Randomized controlled trials
α-AGAL	α-galactosidase A